nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—alcohol dependence—bipolar disorder	0.95	1	CtDrD
Naltrexone—UGT1A1—urine—bipolar disorder	0.00583	0.271	CbGeAlD
Naltrexone—OPRM1—telencephalic ventricle—bipolar disorder	0.00502	0.233	CbGeAlD
Naltrexone—UGT1A1—blood plasma—bipolar disorder	0.00304	0.141	CbGeAlD
Naltrexone—OPRD1—nervous system—bipolar disorder	0.00104	0.0484	CbGeAlD
Naltrexone—OPRK1—nervous system—bipolar disorder	0.001	0.0465	CbGeAlD
Naltrexone—OPRK1—cerebellum—bipolar disorder	0.000942	0.0437	CbGeAlD
Naltrexone—OPRD1—brain—bipolar disorder	0.000798	0.037	CbGeAlD
Naltrexone—OPRK1—brain—bipolar disorder	0.000765	0.0355	CbGeAlD
Naltrexone—OPRM1—nervous system—bipolar disorder	0.000712	0.033	CbGeAlD
Naltrexone—ABCB1—blood plasma—bipolar disorder	0.00069	0.032	CbGeAlD
Naltrexone—OPRM1—brain—bipolar disorder	0.000544	0.0253	CbGeAlD
Naltrexone—ABCB1—adrenal cortex—bipolar disorder	0.00035	0.0163	CbGeAlD
Naltrexone—ABCB1—thyroid gland—bipolar disorder	0.000244	0.0113	CbGeAlD
Naltrexone—ABCB1—nervous system—bipolar disorder	0.000205	0.00953	CbGeAlD
Naltrexone—ABCB1—cerebellum—bipolar disorder	0.000193	0.00897	CbGeAlD
Naltrexone—ABCB1—brain—bipolar disorder	0.000157	0.00728	CbGeAlD
Naltrexone—UGT1A1—Biological oxidations—POMC—bipolar disorder	6.12e-05	0.00215	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—RGS4—bipolar disorder	6.09e-05	0.00214	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—DRD2—bipolar disorder	5.97e-05	0.0021	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—HTR1A—bipolar disorder	5.97e-05	0.0021	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—TRPC3—bipolar disorder	5.91e-05	0.00208	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—TAC1—bipolar disorder	5.88e-05	0.00207	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—DRD5—bipolar disorder	5.78e-05	0.00203	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—HTR2C—bipolar disorder	5.76e-05	0.00203	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—DRD1—bipolar disorder	5.76e-05	0.00203	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—DGKH—bipolar disorder	5.74e-05	0.00202	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—RGS4—bipolar disorder	5.67e-05	0.00199	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—ADM—bipolar disorder	5.64e-05	0.00198	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—DRD3—bipolar disorder	5.58e-05	0.00196	CbGpPWpGaD
Naltrexone—OPRM1—Peptide ligand-binding receptors—POMC—bipolar disorder	5.53e-05	0.00194	CbGpPWpGaD
Naltrexone—OPRK1—G alpha (i) signalling events—POMC—bipolar disorder	5.52e-05	0.00194	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—TSHB—bipolar disorder	5.5e-05	0.00193	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—PDE4B—bipolar disorder	5.5e-05	0.00193	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—TACR1—bipolar disorder	5.5e-05	0.00193	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	5.49e-05	0.00193	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—IMPA1—bipolar disorder	5.47e-05	0.00193	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	5.42e-05	0.00191	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—DRD4—bipolar disorder	5.42e-05	0.00191	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—TRPC3—bipolar disorder	5.37e-05	0.00189	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—DRD5—bipolar disorder	5.25e-05	0.00185	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—TRPC3—bipolar disorder	5.19e-05	0.00182	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—RGS4—bipolar disorder	5.15e-05	0.00181	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—ADM—bipolar disorder	5.12e-05	0.0018	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	5.08e-05	0.00179	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—DRD2—bipolar disorder	5.05e-05	0.00178	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	5e-05	0.00176	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—TSHB—bipolar disorder	4.99e-05	0.00176	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—PDE4B—bipolar disorder	4.99e-05	0.00176	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—TACR1—bipolar disorder	4.99e-05	0.00176	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—AKR1C4—bipolar disorder	4.97e-05	0.00175	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—ADM—bipolar disorder	4.95e-05	0.00174	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—TSHB—bipolar disorder	4.82e-05	0.0017	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—PDE4B—bipolar disorder	4.82e-05	0.0017	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—TACR1—bipolar disorder	4.82e-05	0.0017	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—HTR2A—bipolar disorder	4.77e-05	0.00168	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—TRPC3—bipolar disorder	4.71e-05	0.00166	CbGpPWpGaD
Naltrexone—OPRM1—G alpha (i) signalling events—POMC—bipolar disorder	4.66e-05	0.00164	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—NDUFV2—bipolar disorder	4.65e-05	0.00164	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	4.64e-05	0.00163	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DGKH—bipolar disorder	4.58e-05	0.00161	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR1A—bipolar disorder	4.55e-05	0.0016	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—AKR1C4—bipolar disorder	4.51e-05	0.00159	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—ADM—bipolar disorder	4.49e-05	0.00158	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—TAC1—bipolar disorder	4.48e-05	0.00158	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR2C—bipolar disorder	4.39e-05	0.00155	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—DRD1—bipolar disorder	4.39e-05	0.00155	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	4.39e-05	0.00154	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—TRPC3—bipolar disorder	4.38e-05	0.00154	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—TACR1—bipolar disorder	4.38e-05	0.00154	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—PDE4B—bipolar disorder	4.38e-05	0.00154	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—TSHB—bipolar disorder	4.38e-05	0.00154	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—AKR1C4—bipolar disorder	4.36e-05	0.00153	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—DRD3—bipolar disorder	4.26e-05	0.0015	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DRD5—bipolar disorder	4.19e-05	0.00147	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—HTR2A—bipolar disorder	4.18e-05	0.00147	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—ADM—bipolar disorder	4.18e-05	0.00147	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	4.18e-05	0.00147	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR1A—bipolar disorder	4.13e-05	0.00145	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—DRD4—bipolar disorder	4.13e-05	0.00145	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—RGS4—bipolar disorder	4.1e-05	0.00144	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—PDE4B—bipolar disorder	4.07e-05	0.00143	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—TACR1—bipolar disorder	4.07e-05	0.00143	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—TSHB—bipolar disorder	4.07e-05	0.00143	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—TAC1—bipolar disorder	4.07e-05	0.00143	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—NR1D1—bipolar disorder	4.05e-05	0.00142	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DGKH—bipolar disorder	4.01e-05	0.00141	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR2C—bipolar disorder	3.99e-05	0.0014	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—DRD1—bipolar disorder	3.99e-05	0.0014	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR1A—bipolar disorder	3.99e-05	0.0014	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—TRPC3—bipolar disorder	3.98e-05	0.0014	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—TAC1—bipolar disorder	3.93e-05	0.00138	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—ADCY2—bipolar disorder	3.89e-05	0.00137	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL1B—bipolar disorder	3.88e-05	0.00137	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—NCAN—bipolar disorder	3.87e-05	0.00136	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—DRD3—bipolar disorder	3.87e-05	0.00136	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—DRD1—bipolar disorder	3.85e-05	0.00136	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR2C—bipolar disorder	3.85e-05	0.00136	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—DRD2—bipolar disorder	3.85e-05	0.00135	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	3.83e-05	0.00135	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—POMC—bipolar disorder	3.81e-05	0.00134	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—ADM—bipolar disorder	3.8e-05	0.00134	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—SLC5A3—bipolar disorder	3.79e-05	0.00133	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—DRD4—bipolar disorder	3.75e-05	0.00132	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—DRD3—bipolar disorder	3.73e-05	0.00131	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—IMPA2—bipolar disorder	3.72e-05	0.00131	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	3.72e-05	0.00131	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	3.71e-05	0.0013	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—TACR1—bipolar disorder	3.7e-05	0.0013	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—TSHB—bipolar disorder	3.7e-05	0.0013	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PDE4B—bipolar disorder	3.7e-05	0.0013	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—AKR1C4—bipolar disorder	3.69e-05	0.0013	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DRD5—bipolar disorder	3.67e-05	0.00129	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR1A—bipolar disorder	3.62e-05	0.00127	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—DRD4—bipolar disorder	3.62e-05	0.00127	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—RGS4—bipolar disorder	3.6e-05	0.00127	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—TAC1—bipolar disorder	3.57e-05	0.00126	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—HTR2A—bipolar disorder	3.54e-05	0.00124	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—ADCY2—bipolar disorder	3.53e-05	0.00124	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—DRD1—bipolar disorder	3.5e-05	0.00123	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR2C—bipolar disorder	3.5e-05	0.00123	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—DRD2—bipolar disorder	3.5e-05	0.00123	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—ADCY2—bipolar disorder	3.41e-05	0.0012	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DGKH—bipolar disorder	3.39e-05	0.00119	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—DRD3—bipolar disorder	3.39e-05	0.00119	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—DRD2—bipolar disorder	3.38e-05	0.00119	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR1A—bipolar disorder	3.37e-05	0.00119	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—POMC—bipolar disorder	3.34e-05	0.00118	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—TAC1—bipolar disorder	3.32e-05	0.00117	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—DRD4—bipolar disorder	3.29e-05	0.00116	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR2C—bipolar disorder	3.26e-05	0.00115	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—DRD1—bipolar disorder	3.26e-05	0.00115	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TRPC3—bipolar disorder	3.17e-05	0.00112	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—DRD3—bipolar disorder	3.15e-05	0.00111	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DRD5—bipolar disorder	3.1e-05	0.00109	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—ADCY2—bipolar disorder	3.1e-05	0.00109	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—DRD2—bipolar disorder	3.07e-05	0.00108	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR1A—bipolar disorder	3.06e-05	0.00108	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—DRD4—bipolar disorder	3.06e-05	0.00108	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—RGS4—bipolar disorder	3.04e-05	0.00107	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADM—bipolar disorder	3.03e-05	0.00106	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—TAC1—bipolar disorder	3.02e-05	0.00106	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR2C—bipolar disorder	2.96e-05	0.00104	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—DRD1—bipolar disorder	2.96e-05	0.00104	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TSHB—bipolar disorder	2.95e-05	0.00104	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PDE4B—bipolar disorder	2.95e-05	0.00104	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TACR1—bipolar disorder	2.95e-05	0.00104	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—ADCY2—bipolar disorder	2.88e-05	0.00101	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—DRD3—bipolar disorder	2.86e-05	0.00101	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—DRD2—bipolar disorder	2.85e-05	0.001	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—POMC—bipolar disorder	2.82e-05	0.000993	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—TRPC3—bipolar disorder	2.82e-05	0.000991	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TRPC3—bipolar disorder	2.78e-05	0.000979	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—DRD4—bipolar disorder	2.78e-05	0.000978	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CLOCK—bipolar disorder	2.74e-05	0.000965	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR2A—bipolar disorder	2.7e-05	0.000948	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—TPH2—bipolar disorder	2.67e-05	0.00094	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—TSHB—bipolar disorder	2.67e-05	0.00094	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CACNB2—bipolar disorder	2.67e-05	0.00094	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADM—bipolar disorder	2.65e-05	0.000934	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—DPYD—bipolar disorder	2.63e-05	0.000925	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—ADCY2—bipolar disorder	2.62e-05	0.000921	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—DRD2—bipolar disorder	2.59e-05	0.000911	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PDE4B—bipolar disorder	2.59e-05	0.00091	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TSHB—bipolar disorder	2.59e-05	0.00091	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TACR1—bipolar disorder	2.59e-05	0.00091	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—IMPA1—bipolar disorder	2.51e-05	0.000883	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR2A—bipolar disorder	2.45e-05	0.000861	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CACNA1C—bipolar disorder	2.44e-05	0.00086	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR1A—bipolar disorder	2.44e-05	0.000859	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TAC1—bipolar disorder	2.4e-05	0.000846	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PIK3C2A—bipolar disorder	2.38e-05	0.000838	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR2A—bipolar disorder	2.36e-05	0.000832	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DRD1—bipolar disorder	2.36e-05	0.000829	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR2C—bipolar disorder	2.36e-05	0.000829	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TRPC3—bipolar disorder	2.35e-05	0.000827	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NTRK2—bipolar disorder	2.29e-05	0.000807	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DRD3—bipolar disorder	2.28e-05	0.000803	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GSK3A—bipolar disorder	2.27e-05	0.0008	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADM—bipolar disorder	2.24e-05	0.000789	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DRD4—bipolar disorder	2.22e-05	0.00078	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TSHB—bipolar disorder	2.19e-05	0.000769	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PDE4B—bipolar disorder	2.19e-05	0.000769	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TACR1—bipolar disorder	2.19e-05	0.000769	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—POMC—bipolar disorder	2.15e-05	0.000757	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR2A—bipolar disorder	2.15e-05	0.000755	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR1A—bipolar disorder	2.14e-05	0.000753	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—SNAP25—bipolar disorder	2.14e-05	0.000752	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—NDUFV2—bipolar disorder	2.13e-05	0.000751	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TAC1—bipolar disorder	2.11e-05	0.000742	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADCY2—bipolar disorder	2.09e-05	0.000734	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TCF7L2—bipolar disorder	2.08e-05	0.000731	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—AKR1C4—bipolar disorder	2.07e-05	0.000727	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DRD1—bipolar disorder	2.07e-05	0.000727	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR2C—bipolar disorder	2.07e-05	0.000727	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DRD2—bipolar disorder	2.06e-05	0.000726	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NTRK2—bipolar disorder	2.01e-05	0.000707	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DRD3—bipolar disorder	2e-05	0.000704	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR2A—bipolar disorder	2e-05	0.000703	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GSK3A—bipolar disorder	1.99e-05	0.000701	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—POMC—bipolar disorder	1.96e-05	0.000688	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DRD4—bipolar disorder	1.94e-05	0.000684	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ADCY2—bipolar disorder	1.89e-05	0.000665	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—POMC—bipolar disorder	1.89e-05	0.000664	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NTRK1—bipolar disorder	1.87e-05	0.000658	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	1.87e-05	0.000656	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—NR1D1—bipolar disorder	1.86e-05	0.000653	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	1.85e-05	0.000652	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADCY2—bipolar disorder	1.83e-05	0.000644	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TCF7L2—bipolar disorder	1.82e-05	0.000641	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—S100B—bipolar disorder	1.82e-05	0.000639	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR2A—bipolar disorder	1.81e-05	0.000638	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DRD2—bipolar disorder	1.81e-05	0.000637	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR1A—bipolar disorder	1.81e-05	0.000636	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TAC1—bipolar disorder	1.78e-05	0.000627	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—NCAN—bipolar disorder	1.78e-05	0.000625	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DRD1—bipolar disorder	1.75e-05	0.000615	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR2C—bipolar disorder	1.75e-05	0.000615	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—SLC5A3—bipolar disorder	1.74e-05	0.000612	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—POMC—bipolar disorder	1.71e-05	0.000603	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NTRK2—bipolar disorder	1.7e-05	0.000598	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DRD3—bipolar disorder	1.69e-05	0.000595	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GSK3A—bipolar disorder	1.68e-05	0.000593	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DRD4—bipolar disorder	1.64e-05	0.000578	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NTRK1—bipolar disorder	1.64e-05	0.000577	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—COMT—bipolar disorder	1.62e-05	0.00057	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—MAOA—bipolar disorder	1.61e-05	0.000566	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NRG1—bipolar disorder	1.6e-05	0.000564	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—POMC—bipolar disorder	1.6e-05	0.000561	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—S100B—bipolar disorder	1.59e-05	0.000561	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADCY2—bipolar disorder	1.55e-05	0.000544	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TCF7L2—bipolar disorder	1.54e-05	0.000542	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DRD2—bipolar disorder	1.53e-05	0.000538	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—POMC—bipolar disorder	1.45e-05	0.00051	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR2A—bipolar disorder	1.45e-05	0.000509	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NRG1—bipolar disorder	1.41e-05	0.000495	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NTRK1—bipolar disorder	1.39e-05	0.000487	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—S100B—bipolar disorder	1.35e-05	0.000474	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—MTHFR—bipolar disorder	1.31e-05	0.00046	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR2A—bipolar disorder	1.27e-05	0.000446	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CLOCK—bipolar disorder	1.26e-05	0.000443	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—TPH2—bipolar disorder	1.23e-05	0.000431	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CACNB2—bipolar disorder	1.23e-05	0.000431	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—TSHB—bipolar disorder	1.23e-05	0.000431	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—DPYD—bipolar disorder	1.21e-05	0.000424	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NRG1—bipolar disorder	1.19e-05	0.000418	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GSK3B—bipolar disorder	1.16e-05	0.00041	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—POMC—bipolar disorder	1.16e-05	0.000406	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—INS—bipolar disorder	1.15e-05	0.000404	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CACNA1C—bipolar disorder	1.12e-05	0.000395	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PIK3C2A—bipolar disorder	1.09e-05	0.000384	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR2A—bipolar disorder	1.07e-05	0.000377	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—POMC—bipolar disorder	1.05e-05	0.000368	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—INS—bipolar disorder	1.04e-05	0.000366	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GSK3B—bipolar disorder	1.02e-05	0.000359	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—POMC—bipolar disorder	1.01e-05	0.000356	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—INS—bipolar disorder	1.01e-05	0.000354	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—SNAP25—bipolar disorder	9.8e-06	0.000345	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADCY2—bipolar disorder	8.68e-06	0.000305	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GSK3B—bipolar disorder	8.63e-06	0.000304	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—POMC—bipolar disorder	8.56e-06	0.000301	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—INS—bipolar disorder	8.51e-06	0.000299	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—COMT—bipolar disorder	7.43e-06	0.000261	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MAOA—bipolar disorder	7.38e-06	0.000259	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MTHFR—bipolar disorder	6e-06	0.000211	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—POMC—bipolar disorder	4.8e-06	0.000169	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—INS—bipolar disorder	4.78e-06	0.000168	CbGpPWpGaD
